New targets for stroke treatment and new technologies for efficacy assessment

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300075126

Enrollment

Unknown

Registered

2023-08-25

Start date

2021-08-02

Completion date

Unknown

Last updated

2023-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subarachnoid hemorrhage

Interventions

Case series:None

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: History, signs and imaging consistent with diagnostic criteria for spontaneous subarachnoid haemorrhage

Exclusion criteria

Exclusion criteria: History of trauma, intracranial space-occupying lesions, malignancies, autoimmune diseases and other causes of subarachnoid haemorrhage at the time of onset

Design outcomes

Primary

Measure	Time frame
Index of cerebral vasospasm;	—

Secondary

Measure	Time frame
Index of inflammatory factor;mRS scores;	—

Countries

China

Contacts

Public Contactxijinwang

Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.

wangxijin2004@163.com+86 136 5162 7382

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026